QQ客服 官方微博 反馈留言

	Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study
	Li, Jiali[1]; Chen, Siyang[2]; Qin, Xiaoling[1,3]; Fu, Qian[2]; Bi, Huichang[1]; Zhang, Yu[1,4]; Wang, Xueding[1]; Liu, Longshan[2]; Wang, Changxi[2]; Huang, Min[1]
刊名	DRUG METABOLISM AND DISPOSITION
	2017
卷号	45页码:1114-1119
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2182610
专题	华南理工大学
作者单位	1.[1]Sun Yat Sen Univ, Sch Pharmaceut Sci, Inst Clin Pharmacol, 132 Waihuan Dong Rd, Guangzhou 510006, Guangdong, Peoples R China 2.[2]Sun Yat Sen Univ, Affiliated Hosp 1, Transplant Ctr, Kidney Transplant Dept, Guangzhou, Guangdong, Peoples R China 3.[3]Guangdong Food & Drug Vocat Coll, Guangzhou, Guangdong, Peoples R China 4.[4]Guangzhou Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Li, Jiali[1],Chen, Siyang[2],Qin, Xiaoling[1,3],et al. Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study[J]. DRUG METABOLISM AND DISPOSITION,2017,45:1114-1119.
APA	Li, Jiali[1].,Chen, Siyang[2].,Qin, Xiaoling[1,3].,Fu, Qian[2].,Bi, Huichang[1].,...&Huang, Min[1].(2017).Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study.DRUG METABOLISM AND DISPOSITION,45,1114-1119.
MLA	Li, Jiali[1],et al."Wuzhi Tablet (Schisandra sphenanthera Extract) is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who are CYP3A5 Expressers: a Two-Phase Prospective Study".DRUG METABOLISM AND DISPOSITION 45(2017):1114-1119.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。